Characteristics of microblotting assay using immunoloposomesKUMADA, Yoichi; MAEHARA, Masumi; KATOH, Shigeo et al.Journal of bioscience and bioengineering. 2004, Vol 98, Num 2, pp 129-131, issn 1389-1723, 3 p.Article

Future directions of liposome- and immunoliposome-based cancer therapeuticsPARK, John W; BENZ, Christopher C; MARTIN, Francis J et al.Seminars in oncology. 2004, Vol 31, Num 6, pp 196-205, issn 0093-7754, 10 p., SUP13Article

pH-sensitive immunoliposomes as an efficient and target-specific carrier for antitumor drugsCONNOR, J; HUANG, L.Cancer research (Baltimore). 1986, Vol 46, Num 7, pp 3431-3435, issn 0008-5472Article

Current methods for attaching targeting ligands to Liposomes and nanoparticlesNOBS, Leila; BUCHEGGER, Franz; GURNY, Robert et al.Journal of pharmaceutical sciences. 2004, Vol 93, Num 8, pp 1980-1992, issn 0022-3549, 13 p.Article

Development of anti-HB-EGF immunoliposomes for the treatment of breast cancerNISHIKAWA, Kaoru; ASAI, Tomohiro; SHIGEMATSU, Hirokazu et al.Journal of controlled release. 2012, Vol 160, Num 2, pp 274-280, issn 0168-3659, 7 p.Article

Prodrug-based intracellular delivery of anticancer agentsBILDSTEIN, L; DUBERNET, C; COUVREUR, P et al.Advanced drug delivery reviews. 2011, Vol 63, Num 1-2, pp 3-23, issn 0169-409X, 21 p.Article

Monoclonal antibody-based therapies in cancer: Advances and challengesSAPRA, Puja; SHOR, Boris.Pharmacology & therapeutics (Oxford). 2013, Vol 138, Num 3, pp 452-469, issn 0163-7258, 18 p.Article

Tumor-targeted PE38KDEL delivery via PEGylated anti-HER2 immunoliposomesJIE GAO; WEI ZHONG; DAPENG ZHANG et al.International journal of pharmaceutics (Print). 2009, Vol 374, Num 1-2, pp 145-152, issn 0378-5173, 8 p.Article

A modified protocol for efficient DNA encapsulation into pegylated immunoliposomes (PILs)SKJØRRINGE, Tina; GJETTING, Torben; JENSEN, Thomas G et al.Journal of controlled release. 2009, Vol 139, Num 2, pp 140-145, issn 0168-3659, 6 p.Article

Molecular and magnetic resonance imaging: The value of immunoliposomesKOZLOWSKA, Dorota; FORAN, Paul; MACMAHON, Peter et al.Advanced drug delivery reviews. 2009, Vol 61, Num 15, pp 1402-1411, issn 0169-409X, 10 p.Article

Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinityXIAOGANG PAN; LEE, Robert J.International journal of pharmaceutics. 2007, Vol 336, Num 2, pp 276-283, issn 0378-5173, 8 p.Article

Generation of immunoliposomes using recombinant single-chain FV fragments bound to Ni-NTA-liposomesRÜGER, Ronny; MÜLLER, Dafne; FAHR, Alfred et al.Journal of drug targeting. 2005, Vol 13, Num 7, pp 399-406, issn 1061-186X, 8 p.Article

Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposomeTAO YANG; CHOI, Min-Koo; CUI, Fu-De et al.Journal of controlled release. 2007, Vol 120, Num 3, pp 169-177, issn 0168-3659, 9 p.Article

Target ability and therapy efficacy of immunoliposomes using a humanized antihepatoma disulfide-stabilized Fv fragment on tumor cellsHAIYANG HU; DAWEI CHEN; YANFANG LID et al.Journal of pharmaceutical sciences. 2006, Vol 95, Num 1, pp 192-199, issn 0022-3549, 8 p.Article

Selectins: an emerging target for drug deliveryEHRHARDT, Carsten; KNEUER, Carsten; BAKOWSKY, Udo et al.Advanced drug delivery reviews. 2004, Vol 56, Num 4, pp 527-549, issn 0169-409X, 23 p.Article

ImmunoliposomesPASZKO, E; SENGE, M. O.Current medicinal chemistry. 2012, Vol 19, Num 31, pp 5239-5277, issn 0929-8673, 39 p.Article

Targeted delivery of SiRNA to CD33-positive tumor cells with liposomal carrier systemsROTHDIENER, Miriam; MÜLLER, Dafne; GARRIDO CASTRO, Patricia et al.Journal of controlled release. 2010, Vol 144, Num 2, pp 251-258, issn 0168-3659, 8 p.Article

Cytoskeletal-antigen specific immunoliposome-targeted in vivo preservation of myocardial viabilityKHAW, Ban-An; DASILVA, Jose; HARTNER, William C et al.Journal of controlled release. 2007, Vol 120, Num 1-2, pp 35-40, issn 0168-3659, 6 p.Article

Single-chain Fv immunoliposomes for the targeting of fibroblast activation protein-expressing tumor stromal cellsBAUM, Patrick; MÜLLER, Dafne; RÜGER, Ronny et al.Journal of drug targeting. 2007, Vol 15, Num 6, pp 399-406, issn 1061-186X, 8 p.Article

Colony lift immunoassay utilizing antibody-coupled liposomes encapsulating HRPKUMADA, Yoichi; MAEHARA, Masumi; MINAMI, Naoki et al.Biochemical engineering journal. 2006, Vol 29, Num 1-2, pp 98-102, issn 1369-703X, 5 p.Conference Paper

Anticorps anti-Cryptococcus néoformans : contrôle génétique de la production, intérêt d'un anticorps monoclonal dans le traitement des cryptococcoses expérimentalesDromer, Françoise; Yeni, Patrick.1989, 129 p.Thesis

Mesangial pathology in glomerular disease: targets for therapeutic interventionSCINDIA, Yogesh M; DESHMUKH, Umesh S; BAGAVANT, Harini et al.Advanced drug delivery reviews. 2010, Vol 62, Num 14, pp 1337-1343, issn 0169-409X, 7 p.Article

pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cellsSIMARD, Pierre; LEROUX, Jean-Christophe.International journal of pharmaceutics (Print). 2009, Vol 381, Num 2, pp 86-96, issn 0378-5173, 11 p.Article

Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell lineMARKOUTSA, Eleni; PAMPALAKIS, Georgios; NIARAKIS, Anna et al.European journal of pharmaceutics and biopharmaceutics. 2011, Vol 77, Num 2, pp 265-274, issn 0939-6411, 10 p.Article

Targeting of daunomycin using biotinylated immunoliposomes : Pharmacokinetics, tissue distribution and in vitro pharmacological effectsSCHNYDER, Anita; KRÄHENBÜHL, Stephan; DREWE, Jürgen et al.Journal of drug targeting. 2005, Vol 13, Num 5, pp 325-335, issn 1061-186X, 11 p.Article